Radiotherapy for unilesional mycosis fungoides

Bizhan Micaily(Philadelphia University), Eric C. Vonderheid(Ashford and St Peter's Hospitals NHS Foundation Trust), Stuart R. Lessin(Fox Chase Cancer Center), Alain H. Rook(University of Pennsylvania), Gary R. Kantor(Allegheny College), Curtis Miyamoto(Allegheny College), Luther W. Brady(Allegheny College), Robert L. Goodman(West Virginia University)
International Journal of Radiation Oncology*Biology*Physics
September 1, 1998
10.1016/s0360-3016(98)00218-1
Cited by 116

Related Papers

Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
|Blood|2007|1.4k
Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy
|New England Journal of Medicine|1987|1.2k
Minireview: Kisspeptin/Neurokinin B/Dynorphin (KNDy) Cells of the Arcuate Nucleus: A Central Node in the Control of Gonadotropin-Releasing Hormone Secretion
|Endocrinology|2010|758
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
|Journal of Clinical Oncology|2011|657
Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma
|Journal of Clinical Oncology|2001|610